A carregar...
3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development
Multimodality 3D Optical Imaging (OI)/CT has the potential to play a major role in drug development for glioblastomas (GBM), as it is an accessible preclinical method. To demonstrate the potential of 3D OI/CT to visualize orthotopic GBM implantation, we labeled GBM cells with Cy7 and imaged their lo...
Na minha lista:
| Publicado no: | Drug Deliv |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7717859/ https://ncbi.nlm.nih.gov/pubmed/33263448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1833381 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|